• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙敏感受体在子宫内膜癌中的抑制作用。

The suppressive role of calcium sensing receptor in endometrial cancer.

机构信息

Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1277, Jiefang Avenue, Jiangan District, Wuhan, 430022, PR China.

Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, No.13, Hangkong Road, Qiaokou District, Wuhan, 430030, PR China.

出版信息

Sci Rep. 2018 Jan 18;8(1):1076. doi: 10.1038/s41598-018-19286-1.

DOI:10.1038/s41598-018-19286-1
PMID:29348629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5773571/
Abstract

Studies have shown that calcium sensing receptor (CaSR) is involved in the progressions of several human cancers. However, the role of CaSR in endometrial cancer remains unknown. This study provides a preliminary analysis of the CaSR effect on endometrial cancer development. Ectopic CaSR expression by lentiviral transfection (CaSR-OV) in Ishikawa cells significantly increased intracellular calcium ([Ca]) levels and cell apoptosis. E-cadherin and β-catenin expression and complex formation at the membrane were increased in CaSR-OV Ishikawa cells relative to control Ishikawa cells (vector). Furthermore, CaSR-OV Ishikawa cells showed a reduced invasive potential, which was attributed to E-cadherin/β-catenin complex formation. Moreover, a reduction in CaSR expression in endometrial cancer relative to normal specimens was evident by immunohistochemistry and was positively associated with E-cadherin, but not β-catenin, expression. Furthermore, VEGFR3 was significantly down-regulated in CaSR-OV Ishikawa cells. Additionally, an immunohistochemical analysis showed that VEGFR3 was significantly increased in endometrial cancer compared with the normal endometrium and was inversely correlated with CaSR expression. However, the CaSR knockdown produced the opposite effects. These findings suggest an inhibitory role for CaSR in endometrial cancer. Therefore, reduced CaSR expression may be a suitable explanation and valuable predictor for endometrial cancer progression.

摘要

研究表明钙敏感受体(CaSR)参与了多种人类癌症的进展。然而,CaSR 在子宫内膜癌中的作用尚不清楚。本研究初步分析了 CaSR 对子宫内膜癌发展的影响。通过慢病毒转染(CaSR-OV)异位表达 CaSR 在 Ishikawa 细胞中显著增加了细胞内钙离子([Ca])水平和细胞凋亡。与对照 Ishikawa 细胞(载体)相比,CaSR-OV Ishikawa 细胞中 E-钙粘蛋白和β-连环蛋白的表达和膜上复合物的形成增加。此外,CaSR-OV Ishikawa 细胞的侵袭潜能降低,这归因于 E-钙粘蛋白/β-连环蛋白复合物的形成。此外,免疫组织化学显示,与正常标本相比,子宫内膜癌中 CaSR 的表达降低,并且与 E-钙粘蛋白表达呈正相关,而与β-连环蛋白表达无关。此外,在 CaSR-OV Ishikawa 细胞中 VEGFR3 的表达显著下调。此外,免疫组织化学分析显示,与正常子宫内膜相比,子宫内膜癌中 VEGFR3 的表达显著增加,并且与 CaSR 表达呈负相关。然而,CaSR 敲低产生了相反的效果。这些发现表明 CaSR 在子宫内膜癌中具有抑制作用。因此,CaSR 表达降低可能是子宫内膜癌进展的一个合适的解释和有价值的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/3fd553e3b841/41598_2018_19286_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/114ee3712c57/41598_2018_19286_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/c2fc1d2ac38a/41598_2018_19286_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/6c5515206fd9/41598_2018_19286_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/971e0ef33464/41598_2018_19286_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/db1b45c64f6c/41598_2018_19286_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/3fd553e3b841/41598_2018_19286_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/114ee3712c57/41598_2018_19286_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/c2fc1d2ac38a/41598_2018_19286_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/6c5515206fd9/41598_2018_19286_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/971e0ef33464/41598_2018_19286_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/db1b45c64f6c/41598_2018_19286_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6e/5773571/3fd553e3b841/41598_2018_19286_Fig6_HTML.jpg

相似文献

1
The suppressive role of calcium sensing receptor in endometrial cancer.钙敏感受体在子宫内膜癌中的抑制作用。
Sci Rep. 2018 Jan 18;8(1):1076. doi: 10.1038/s41598-018-19286-1.
2
Regulation of E-cadherin and beta-catenin by Ca2+ in colon carcinoma is dependent on calcium-sensing receptor expression and function.结肠癌中钙离子对E-钙黏蛋白和β-连环蛋白的调节取决于钙敏感受体的表达和功能。
Int J Cancer. 2007 Oct 1;121(7):1455-62. doi: 10.1002/ijc.22858.
3
Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer.钙敏感受体缺失细胞的分离与鉴定:结肠癌的一种高度恶性和耐药表型。
Int J Cancer. 2013 May 1;132(9):1996-2005. doi: 10.1002/ijc.27902. Epub 2012 Nov 2.
4
Calcium sensing receptor suppresses human pancreatic tumorigenesis through a novel NCX1/Ca(2+)/β-catenin signaling pathway.钙敏感受体通过一种新的NCX1/Ca(2+)/β-连环蛋白信号通路抑制人胰腺肿瘤发生。
Cancer Lett. 2016 Jul 10;377(1):44-54. doi: 10.1016/j.canlet.2016.04.027. Epub 2016 Apr 20.
5
Calcium Promotes Human Gastric Cancer via a Novel Coupling of Calcium-Sensing Receptor and TRPV4 Channel.钙通过钙敏感受体和 TRPV4 通道的新型偶联促进人胃癌。
Cancer Res. 2017 Dec 1;77(23):6499-6512. doi: 10.1158/0008-5472.CAN-17-0360. Epub 2017 Sep 26.
6
Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action.钙敏感受体激动剂增加血管平滑肌细胞中钙敏感受体的表达并减少矿化作用:作用机制。
Cardiovasc Res. 2014 Feb 1;101(2):256-65. doi: 10.1093/cvr/cvt249. Epub 2013 Nov 11.
7
Calcium-sensing receptors induce apoptosis during simulated ischaemia-reperfusion in Buffalo rat liver cells.钙敏感受体在模拟缺血再灌注期间诱导布法罗大鼠肝细胞凋亡。
Clin Exp Pharmacol Physiol. 2011 Sep;38(9):605-12. doi: 10.1111/j.1440-1681.2011.05559.x.
8
Involvement of calcium-sensing receptor in inhibition of lipolysis through intracellular cAMP and calcium pathways in human adipocytes.钙敏感受体通过细胞内 cAMP 和钙途径抑制人脂肪细胞脂解作用。
Biochem Biophys Res Commun. 2011 Jan 7;404(1):393-9. doi: 10.1016/j.bbrc.2010.11.129. Epub 2010 Dec 3.
9
Morpholino oligonucleotide knockdown of the extracellular calcium-sensing receptor impairs early skeletal development in zebrafish.Morpholino 寡核苷酸敲低细胞外钙敏感受体可损害斑马鱼早期骨骼发育。
Comp Biochem Physiol A Mol Integr Physiol. 2013 Nov;166(3):470-81. doi: 10.1016/j.cbpa.2013.07.027. Epub 2013 Aug 1.
10
Significance of calcium-sensing receptor expression in gastric cancer.钙敏感受体表达在胃癌中的意义。
Scand J Gastroenterol. 2016 Jan;51(1):67-72. doi: 10.3109/00365521.2015.1064993. Epub 2015 Jul 8.

引用本文的文献

1
Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention.子宫内膜癌中的钙和钙相关蛋白:药理学干预的机会。
Int J Biol Sci. 2022 Jan 1;18(3):1065-1078. doi: 10.7150/ijbs.68591. eCollection 2022.
2
Calcium Sensing Receptor Inhibits Growth of Human Lung Adenocarcinoma Possibly via the GSK3β/Cyclin D1 Pathway.钙敏感受体可能通过GSK3β/细胞周期蛋白D1途径抑制人肺腺癌生长。
Front Cell Dev Biol. 2020 Jun 25;8:446. doi: 10.3389/fcell.2020.00446. eCollection 2020.
3
Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.

本文引用的文献

1
Enhanced Proliferation of Porcine Bone Marrow Mesenchymal Stem Cells Induced by Extracellular Calcium is Associated with the Activation of the Calcium-Sensing Receptor and ERK Signaling Pathway.细胞外钙诱导猪骨髓间充质干细胞增殖增强与钙敏感受体及ERK信号通路激活有关。
Stem Cells Int. 2016;2016:6570671. doi: 10.1155/2016/6570671. Epub 2016 Mar 30.
2
S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.S100A4 通过调节上皮-间充质转化促进子宫内膜癌的进展。
Oncol Rep. 2016 Jun;35(6):3419-26. doi: 10.3892/or.2016.4760. Epub 2016 Apr 20.
3
Calcium sensing receptor suppresses human pancreatic tumorigenesis through a novel NCX1/Ca(2+)/β-catenin signaling pathway.
一石二鸟:双重打击肿瘤生长和淋巴管生成通过靶向血管内皮生长因子受体 3。
Cells. 2019 Mar 21;8(3):270. doi: 10.3390/cells8030270.
4
Calcium-sensing receptor in colorectal inflammation and cancer: Current insights and future perspectives.结直肠炎症和癌症中的钙敏感受体:当前的认识和未来的展望。
World J Gastroenterol. 2018 Sep 28;24(36):4119-4131. doi: 10.3748/wjg.v24.i36.4119.
5
Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.化疗耐药与生长因子/细胞因子信号通路靶向:迈向子宫内膜癌有效治疗策略的发展
Am J Cancer Res. 2018 Jul 1;8(7):1317-1331. eCollection 2018.
钙敏感受体通过一种新的NCX1/Ca(2+)/β-连环蛋白信号通路抑制人胰腺肿瘤发生。
Cancer Lett. 2016 Jul 10;377(1):44-54. doi: 10.1016/j.canlet.2016.04.027. Epub 2016 Apr 20.
4
The calcium-sensing receptor and the hallmarks of cancer.钙敏感受体与癌症的特征
Biochim Biophys Acta. 2016 Jun;1863(6 Pt B):1398-407. doi: 10.1016/j.bbamcr.2015.11.017. Epub 2015 Nov 30.
5
Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update.子宫内膜样子宫内膜癌中的肿瘤进展、转移及上皮-间质转化调节因子:最新进展
Endocr Relat Cancer. 2016 Feb;23(2):R85-R111. doi: 10.1530/ERC-15-0218. Epub 2015 Nov 4.
6
Endometrial Cancer Stem Cell as a Potential Therapeutic Target.子宫内膜癌干细胞作为一种潜在的治疗靶点。
Semin Reprod Med. 2015 Sep;33(5):341-9. doi: 10.1055/s-0035-1563407. Epub 2015 Aug 18.
7
ERK signaling mediates CaSR-promoted axon growth.细胞外调节蛋白激酶(ERK)信号传导介导钙敏感受体(CaSR)促进的轴突生长。
Neurosci Lett. 2015 Aug 31;603:77-83. doi: 10.1016/j.neulet.2015.07.019. Epub 2015 Jul 19.
8
Effect of extracellular calcium on regucalcin expression and cell viability in neoplastic and non-neoplastic human prostate cells.细胞外钙对人肿瘤性和非肿瘤性前列腺细胞中调节钙素表达及细胞活力的影响。
Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2621-8. doi: 10.1016/j.bbamcr.2015.07.006. Epub 2015 Jul 11.
9
The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell- like phenotype in the colon.钙敏感受体抑制结肠中的上皮-间质转化和干细胞样表型。
Mol Cancer. 2015 Mar 18;14:61. doi: 10.1186/s12943-015-0330-4.
10
The calcium-sensing receptor: A promising target for prevention of colorectal cancer.钙敏感受体:预防结直肠癌的一个有前景的靶点。
Biochim Biophys Acta. 2015 Sep;1853(9):2158-67. doi: 10.1016/j.bbamcr.2015.02.011. Epub 2015 Feb 18.